Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2313027
Max Phase: Preclinical
Molecular Formula: C50H56N10O20S2
Molecular Weight: 1181.18
Molecule Type: Unknown
Associated Items:
ID: ALA2313027
Max Phase: Preclinical
Molecular Formula: C50H56N10O20S2
Molecular Weight: 1181.18
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c4ccc(NCc5cnc6nc(N)[nH]c(=O)c6n5)cc4)C(=O)O)C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1O
Standard InChI: InChI=1S/C50H56N10O20S2/c1-77-34-10-4-23(16-33(34)62)2-3-24-14-28(61)17-29(15-24)79-48-41(68)40(67)39(66)35(80-48)21-54-50(76)78-12-13-81-82-22-32(47(74)75)58-44(70)31(18-37(64)65)56-36(63)11-9-30(46(72)73)57-43(69)25-5-7-26(8-6-25)52-19-27-20-53-42-38(55-27)45(71)60-49(51)59-42/h2-8,10,14-17,20,30-32,35,39-41,48,52,61-62,66-68H,9,11-13,18-19,21-22H2,1H3,(H,54,76)(H,56,63)(H,57,69)(H,58,70)(H,64,65)(H,72,73)(H,74,75)(H3,51,53,59,60,71)/b3-2+/t30-,31-,32-,35+,39+,40-,41+,48+/m0/s1
Standard InChI Key: VLTIZSJSAYEPSN-VLNJFSJASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1181.18 | Molecular Weight (Monoisotopic): 1180.3114 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Liang X, Sun Y, Zeng W, Liu L, Ma X, Zhao Y, Fan J.. (2013) Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate., 21 (1): [PMID:23177726] [10.1016/j.bmc.2012.10.044] |
Source(1):